Updating results

4 results for Hydralazine

Sort: Relevance | Date

Insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure (IPG463)

Evidence-based recommendations on the insertion and use of implantation pulmonary artery pressure monitors for chronic heart failure

Interventional procedures guidance Published August 2013

Chronic heart failure in adults: diagnosis and management (NG106)

This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.

NICE guideline Published September 2018

Hypertension in pregnancy: diagnosis and management (NG133)

This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for women with hypertension who wish to conceive and women who have had a pregnancy complicated by hypertension. It aims to improve care during pregnancy, labour and birth for women and their babies.

NICE guideline Published June 2019

Renin-angiotensin system drugs: dual therapy (KTT2)

options are adding an aldosterone antagonist licensed for heart failure or hydralazine in combination with nitrate.

Key therapeutic topic Published January 2015 Last updated February 2016